Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3224 Target Snapshot

C-8 sterol isomerase ERG2 · SINGLE PROTEIN · Saccharomyces cerevisiae S288c

68Compounds
11Assays
10Approved Drugs
43.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P32352. Use UniProt P32352 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P32352 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats C-8 sterol isomerase ERG2 as ChEMBL target CHEMBL3224, mapped to UniProt P32352. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
C-8 sterol isomerase ERG2
SINGLE PROTEIN · Saccharomyces cerevisiae S288c
As of 2026-09-13
ChEMBL target ID
CHEMBL3224
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P32352
C-8 sterol isomerase ERG2
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether C-8 sterol isomerase ERG2 is the right protein anchor across sources, using UniProt P32352 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelC-8 sterol isomerase ERG2
UniProt AccessionP32352
Component TypeProtein
Sequence Length222 aa

C-8 sterol isomerase ERG2

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as C-8 sterol isomerase ERG2, mapped to UniProt P32352. Sequence length is 222 aa.

Mapped IDP32352
Review nameC-8 sterol isomerase ERG2
OrganismSaccharomyces cerevisiae S288c
Clinical Profile

Clinical Phase Distribution

10
Approved
2
Phase III
5
Phase II
Assay Mix

Activity Type Distribution

KI43.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL372700 10.3 Ki 0.05 Preclinical
CHEMBL365842 10.05 Ki 0.09 Preclinical
CHEMBL15023 9.82 Ki 0.15 Clinical
CHEMBL365141 9.7 Ki 0.2 Preclinical
CHEMBL17470 9.4 Ki 0.4 Preclinical
CHEMBL54 9.3 Ki 0.5 Approved
CHEMBL190631 9.15 Ki 0.7 Preclinical
CHEMBL113830 9.0 Ki 1.0 Preclinical
CHEMBL167779 8.7 Ki 2.0 Clinical
CHEMBL187709 8.7 Ki 2.0 Approved
Distribution

pChEMBL Value Distribution

4
5.0
5
5.5
4
6.0
6
6.5
5
7.0
2
7.5
2
8.0
2
8.5
4
9.0
2
9.5
pChEMBL
Approved Drugs

Approved Drugs

RALOXIFENE
CHEMBL81
Approved 1997
NAFTIFINE
CHEMBL626
Approved 1988
AMIODARONE
CHEMBL633
Approved 1985
HALOPERIDOL
CHEMBL54
Approved 1967
TRIFLUOPERAZINE
CHEMBL422
Approved 1959
Assay Landscape

Assay Landscape

11
Total Assays
40
Tested Compounds
1
Assay Types
Binding — 11 assays, 40 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 11 40 7.2

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine